NEU neuren pharmaceuticals limited

Ann: Annual Report to shareholders, page-25

  1. 402 Posts.
    lightbulb Created with Sketch. 40
    I'm with you POS. After the positive Rett results I never thought this SP territory would be revisited. There isn't even a bad trial result to cause it to drop it back nearly 50%. Plus there are 3 further top line results in 2nd half 2015.

    The churning of these converted options is creating some brilliant buying opportunities leading up to the next run of results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.55 235 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.